•Centromedian thalamic DBS can be considered as a “rescue” treatment of sRSE.•High frequency CMN-DBS improve generalised seizures reducing intensive care time.•CMN-DBS could potentially help to avoid serious side effects srSE medication.•Low reduce severity and focal/multifocal seizures. Super refractory status epilepticus (srSE) refers SE that fails respond 1st 2nd line treatments persists aft...

The data on cannabis and its components for treatment of neurological disorders are plentiful, according to Michele Faulkner, PharmD, FASHP. “Cannabis is a huge topic,” said Faulkner during an APhA2021 Virtual session products treat disorders.Most pharmacists probably familiar with as epilepsy. In 2018, FDA approved Epidiolex (Greenwich Biosciences) the first-ever product containing cannabidiol...

Pharmacists know patients are using cannabis or taking cannabidiol (CBD) for things like insomnia and pain—use of these products is only growing as the number different cannabinoid formulations. But little known about unintended interactions between cannabinoids medications. Right now, pharmacists other health care providers don't have system alerts that can pop up with contraindications in com...